NCVH Leadership Conference Chairmen, New Cardiovascular Horizons

New Cardiovascular Horizons Leadership

  • Dr. Craig M. Walker, MD

    Craig M. Walker, MD

    Clinical Professor of Medicine
    LSU School of Medicine
    New Orleans, LA
    Clinical Professor of Medicine
    Tulane University School of Medicine
    New Orleans, LA
    Founder, President and Medical Director
    Cardiovascular Institute of the South
    Houma, LA

    New Cardiovascular Horizons Annual Conference Founder and Chairman

    Dr. Craig M. Walker, a native of Bourg, Louisiana, is a graduate of Nicholls State University in Thibodaux, Louisiana and LSU School of Medicine in New Orleans. He began his postgraduate training with an internship and residency at Lafayette Charity Hospital in Lafayette, Louisiana. He continued his training with a cardiology fellowship at Ochsner Foundation Hospital in New Orleans and a research fellowship at Harvard Medical School in Boston, Massachusetts.

    In 1983, Dr. Walker returned to south Louisiana to establish the Houma Heart Clinic as a center for the development of new and improved techniques for the treatment of both coronary and peripheral arterial disease. The clinic grew to become Cardiovascular Institute of the South, a world-renowned practice with 37 physicians and nearly 500 team members in 13 locations through south Louisiana.

    Dr. Walker co-founded one of the largest peripheral conferences in the nation, New Cardiovascular Horizons, to educate and train medical professionals on the latest techniques and technology in the field. He also maintains the distinct title of primary investigator for several cardiovascular and peripheral devices. Through his extensive knowledge and research in peripheral vascular disease (PVD), Dr. Walker provides comprehensive educational training courses to other physicians from around the world.

  • Frank T. Bunch, MD

    Cardiology Associates of Mobile
    Mobile, AL

    Chairman, New Cardiovascular Horizons Mobile, AL

    Dr. Frank T. Bunch is a board-certified interventional cardiologist practicing with Cardiology Associates of Mobile, in Mobile, Alabama. He received his cardiology training at Ochsner Medical Center, New Orleans, Louisiana and interventional cardiology training at Alton Ochsner Medical Foundation, New Orleans, LA.

    He has received certifications at the American Board of Internal Medicine and Subspecialty Board in Cardiovascular Disease. Dr. Bunch is also a member of the American College of Physicians, Society of Angiography and Interventions, American Society of Internal Medicine, American Society of Nuclear Cardiology, International Society for Endovascular Surgery and the Horizons International Peripheral Group.

    He is a consultant to a multitude of medical device companies and has been involved in many clinical trials for major device firms.

  • Thomas P. Davis, MD

    St. John Hospital and Eastlake Cardiovascular
    St. Claire Shores, MI

    Chairman, New Cardiovascular Horizons Detroit, MI

    Dr. Thomas Davis is the Director of the Cardiac Catheterization Lab and Director of Peripheral Interventions and Disease at St. John Hospital and Medical Center. In a rapidly changing field where emerging technologies and innovative medications change the landscape, Dr. Davis navigates the innovations to ensure top quality patient care. Finding great interest in the changes of heart care, Dr. Davis looks for the best treatment options to achieve the best outcomes for his patients.

    Finding his passion, Dr. Davis specializes in peripheral arterial disease non-surgical limb salvage. A pioneer in lower extremity arterial disease and stenting as well as carotid artery stenting, Dr. Davis participates on scientific advisory boards for interventional device development, and he is involved in multiple clinical trials for new technology in endovascular therapies. Dr. Davis also shares his vast knowledge through lectures he gives across the country. A true advocate, Dr. Davis is also the Director of the Detroit Chapter “Save a Limb, Save a Life”.

    Dr. Davis received his medical degree from St. George’s University in Grenada, and he completed his residency in internal medicine, cardiology and interventional cardiology at Henry Ford Hospital in Detroit. Dr. Davis is board certified through the American Board of Internal Medicine and Cardiovascular Diseases and Interventional Cardiology.

  • W. Britton Eaves, MD

    Willis Knighton-Bossier
    Bossier City, LA

    Chairman, New Cardiovascular Horizons Shreveport, LA

    Dr. Eaves is a native of Merryville, LA and a graduate of Northwestern State University in Natchitoches, LA. He attended LSU School of Medicine in Shreveport where he also completed his fellowship in cardiology. Dr. Eaves began his private practice in Bossier City, LA with Cardiovascular Consultants, LLC and is credited with starting the first interventional peripheral vascular disease program in the area. He is the Head of Cardiology at Willis Knighton-Bossier and serves as Chairman of Endovascular Treatment for Willis Knighton Health System.

    Dr. Eaves developed an interest and subsequently a passion for the treatment of peripheral vascular disease after working with Dr. Craig Walker in Lafayette, LA. He has been on faculty for New Cardiovascular Horizons, New Orleans for five years. He is also a member of the Horizons International Peripheral Group where he currently serves on the research committee. Dr. Eaves recognizes the importance of quality research and has participated in many clinical and interventional trials for the treatment of peripheral vascular disease. He is board certified in internal medicine, cardiovascular disease and interventional cardiology.

  • Robert Foster, MD

    Birmingham Heart Clinic
    Birmingham, AL

    Chairman, New Cardiovascular Horizons Birmingham, AL

    Dr. Robert Foster was born in Texas and grew up in LaGrange, Georgia. After graduating from Baylor University in Waco, Texas, Dr. Foster earned his medical degree from the University of Alabama in Birmingham and won two awards for medical student research competition. His Internal Medicine training was at the University of Texas Southwestern Health Science Center in Dallas where he received the John S. Miller Award for outstanding performance as a House Officer. Dr. Foster completed his cardiology training at the University of Alabama Medical Center in Birmingham.

    After a year as a UAB faculty member, Dr. Foster joined Birmingham Heart Clinic in 1997 where he has been an interventional cardiologist for 12 years and specializes in peripheral artery disease.

    Dr. Foster and his wife, Donna, have three children. The family is active in numerous missionary activities through their church at Liberty Park Baptist Church where he serves as a deacon. Dr. Foster enjoys hunting, cycling and running.

  • James E. Klemis, MD

    Stern Cardiovascular Foundation
    Memphis, TN

    Chairman, New Cardiovascular Horizons Mid-South, Memphis, TN

    With an extensive background in internal medicine and cardiology, Dr. Klemis went on to pursue additional training in vascular medicine and learned innovative less invasive treatments for vascular disease at the prestigious Lenox Hill Heart and Vascular Institute of New York, one of the busiest centers in the world for vascular disease and the leading center for carotid artery stenting in the US. He worked alongside pioneers in the field of vascular intervention and became the first mid-south physician to become board certified in both vascular medicine and endovascular intervention, as recognized by the American Board of Vascular Medicine.

    Dr. Klemis recognizes the systemic nature of vascular disease and believes a comprehensive evaluation should include attention to all areas affected by vascular disease, not simply the heart. He is currently helping to develop innovative protocols to determine the etiology of stroke and that would help reduce the risk of future therapies. Above all, he values skilled and compassionate care and feels each patient should be treated as if they were a family member. "I was drawn to Memphis after looking at a map and seeing that it was the epicenter of stroke and vascular disease in the United States. I feel that with collaboration among area physicians, we can work together to recognize, prevent, and treat vascular disorders".

  • Richard C. Kovach, MD

    Deborah Heart and Lung Center
    Browns Mills, New Jersey

    Chairman, New Cardiovascular Horizons New Jersey

    Dr. Kovach is currently Chair of Interventional Cardiology at Deborah Heart and Lung Center, Browns Mills, NJ, where he is also Director of The Adult Cardiac Catheterization Laboratory and Director of the Interventional Cardiology Fellowship Program. He completed his Interventional as well as his General Cardiology Fellowship training at Thomas Jefferson University, Philadelphia, Pennsylvania, where he also attended Medical School. Undergraduate work was completed at Johns Hopkins University.

    Dr. Kovach's specific interests include peripheral vascular intervention, as well as structural heart disease and clinical research. Currently at Deborah Heart and Lung Center there are over 30 protocols actively enrolling or in follow-up.

  • Luis R. Leon, MD

    University of Arizona Health Science Center
    Tucson, AZ

    Course Director, New Cardiovascular Horizons Tucson, AZ

    Dr. Luis Leon attended the Cayetano Heredia Peruvian University, obtaining his Medical degree in 1996. He received surgical training at Harbor-UCLA Medical Center and San Joaquin General Hospital in California, from 1997 to 2003. In addition, Dr. Leon completed a Vascular and Endovascular Fellowship at Loyola University Medical Center in 2005. He is certified by the American Board of Surgery in both General and Vascular Surgery. He has been a Registered Vascular Technologist since 2004 and became a Fellow of the American College of Surgeons in 2008. Dr. Leon served as the Chief of Vascular Surgery at the Veterans Affairs Hospital in Tucson from 2005 until 2008. During his tenure at the VA hospital, he belonged to several committees, including the Research and Development, Limb Preservation and Peer Review Committees.

    Dr. Leon has authored over 70 peer-reviewed publications and over 10 book chapters. He serves as a reviewer for several specialty journals, including the Journal of Vascular Surgery and Annals of Vascular Surgery. He is a member of several professional societies, including The Society for Vascular Surgery and The International Society for Vascular Surgery. His academic productivity has earned him a number of awards, including the Charles C Guthrie Award from the Midwestern Vascular Surgery Society in 2004 and the very prestigious E.J. Wylie Traveling Fellowship Award from the American Vascular Association in 2007. His productivity also earned him an Associate Professor of Surgery degree at the University of Arizona, tenure-eligible, since April 2008.

    He has a strong interest in both the research and clinical aspects of carotid, aortic and venous disease.

  • Carlos Mena, MD

    Yale School of Medicine
    New Haven, CT

    Chairman, New Cardiovascular Horizons Fellows Course

    Dr. Carlos Mena, a native of Medellin, Colombia, is a graduate of the University of Antioquia School of Medicine. He began his postgraduate training at Yale University where he completed his internship and residency in addition to his Cardiology and Interventional Cardiology Fellowships. With a strong desire to provide quality clinical research, Dr. Mena leads many studies in his duty as Principal Investigator. His hard work and dedication has been recognized as he earned both the John W. Brackett Award for Resident Teacher and the Ralph I. Horwitz Research in Residency Award.

    In addition to his busy practice, Dr. Mena is a well published physician with a wide range of article publications and book chapters through the contribution of his expertise in Oxford American Handbook of Cardiology. Dr. Mena served as a Course Director for New Cardiovascular Horizons 2012 and is actively involved in local, national and international conferences through his many diverse presentations.

    He maintains many professional associations including the Society of Vascular Medicine, American Heart Association, Fellow of Society Cardiac Angiography and Intervention (F.S.C.A.I.) and Fellow of the American College of Cardiology (F.A.C.C.). Dr. Mena is Board Certified in Internal Medicine, Echocardiography, Cardiovascular Disease, and Interventional Cardiology.

  • Miguel Montero-Baker, MD

    Pima Vascular and Tucson Medical Center
    Tucson, AZ

    San Juan de Dios Hospital
    San Jose, Costa Rica

    Chairman, New Cardiovascular Horizons Latin America

    Dr. Miguel Montero-Baker is a Vascular and Endovascular Surgeon. He graduated with honors both from medical school and his residency in Vascular Surgery. As he finished his residency, he was awarded a DAAD scholarship to further pursue his interest in interventional therapies in Leipzig, Germany. There, he completed a peripheral vascular ultrasound fellowship and an advanced peripheral vascular interventions fellowship.

    Dr. Montero-Baker is a well-recognized opinion leader for the Latin American medical community and active member of the Horizons International Peripheral Group. His main clinical interests are critical limb ischemia and aortic aneurysms.

  • John P. Pacanowski, MD

    Agave Surgical Associates
    Tucson, AZ

    Course Director, New Cardiovascular Horizons Tucson, AZ

    Dr Pacanowski graduated from Pennsylvania State University in 1990 with a Bachelor’s degree in Biology/ Genetics and Developmental Biology. He then attended St. George's University in Grenada to complete his Medical degree. Dr. Pacanowski finished his surgical internship and residency at the University of Tennessee Medical Center where he also concluded his Vascular Fellowship in 2003.

    In addition, Dr. Pacanowski is an accomplished research scholar receiving many academic awards including the Endovascular Fellow's Research Award in 2002 and 2003, as well as the Southern Association of Vascular Surgery, Founders Award in 2003. He is the author of numerous journal publications and has co-authored several text book chapters.

    Dr. Pacanowski is certified by the American Board of Surgery in both General and Vascular Surgery and has advanced qualifications in Endovascular surgical procedures.

  • Raghotham R. Patlola, MD

    Cardiovascular Institute of the South
    Lafayette, LA

    Chairman, New Cardiovascular Horizons Lafayette, LA

    Dr. Raghotham Patlola received his undergraduate degree and medical education from B.L.D.E. Association’s Medical College Hospital and Research Center, Karnataka University in his native India. His postgraduate training included an internal medicine internship and residency at Long Island College Hospital in Brooklyn and a cardiology fellowship through the Beth-Israel Medical Center at Albert Einstein College of Medicine in New York, New York. Dr. Patlola continued his interventional cardiology training at Maimonides Medical Center State University of New York in Brooklyn.

    Dr. Patlola is board certified in internal medicine, cardiovascular disease, interventional cardiology, nuclear cardiology, and endovascular medicine. He is designated as a Hypertension Specialist by the American Society of Hypertension, and he is a Fellow of the American College of Cardiology and a member of the American Medical Association.

    He has hospital privileges at Dauterive Hospital, Iberia Medical Center, Regional Medical Center of Acadiana, Women’s and Children’s Hospital in Lafayette, Our Lady of Lourdes Regional Medical Center, Terrebonne General Medical Center, and Lafayette General Medical Center. Dr. Patlola is a well-published author in numerous articles and he is involved in several clinical and interventional device based trials as the primary or sub investigator.

  • Guy R. Pupp, DPM

    Residency Training Committee
    Providence Hospital
    Dearborn, MI

    Chairman, New Cardiovascular Horizons Detroit, MI

    Dr. Guy Pupp's career which spans over 30 years has helped revolutionize foot and ankle care, especially for those with Diabetes and related co-morbidities. He was a former Section Editor for The Journal of Foot and Ankle Surgery and has been involved in Residency and Fellowship training of over 180 physicians.

    He was recently named one of America's 175 Most Influential Podiatrists by his peers at Podiatry Management Magazine. Dr. Pupp is very involved with the American Diabetes Association named to the Board of Directors for the Michigan Leadership Council. He has published over 35 papers and has lectured both nationally and internationally. One of his studies over 15 years ago advocated a Team Approach to Diabetic Limb Salvage, now an accepted norm. He has studied external fixation technique both in the U.S. and Europe utilizing these techniques in Complex Limb Salvage cases.

  • Oscar Rosales, MD

    Memorial Hermann Hospital-TMC
    Houston, TX

    Chairman, Horizons International Peripheral Group Research Committee

    Dr. Oscar Rosales is a board-certified interventional cardiologist and currently the President of Medical Staff for Memorial Hermann Hospital in Houston, Texas. He completed his medical training at Tulane University, New Orleans, Louisiana; Yale University, New Haven, CT and University of Texas Medical School, Houston, Texas. Dr. Rosales is also the Medical Director of the Memorial Hermann Hospital Cath Lab.

    Dr. Rosales founded the Houston Center for Vascular Health, a non-profit foundation devoted to the dissemination of knowledge about PVD, training of physicians and the investigation of new treatment modalities for PVD. He has participated in many clinical trials and has served on the Medical Advisory Board of several medical device companies. He has pioneered the use of stents in tibioperoneal vessels to treat refractory Critical Limb Ischemia.

    Dr. Rosales has also received the following awards Humanism in Medicine Award, 2002, Alpha Omega Alpha Teacher of the Year as well as multiple teaching awards from the Tulane, Ochsner Clinic and UT Medical School in Houston.

  • Michael T. Simpson, MD

    Birmingham Heart Clinic
    Birmingham, AL

    Chairman, New Cardiovascular Horizons Birmingham, AL

    Dr. Michael T. Simpson was born in Gainesville, Georgia, graduated from Georgia Southern University and the Medical College of Georgia where he was President of his Junior and Senior classes. In medical school he received the Walter L. Shepard Achievement Award for Excellence in the School of Medicine. Dr. Simpson completed his internship and residency in Internal Medicine, and his fellowship in Cardiology at the University of Alabama at Birmingham (UAB). After starting practice in LaGrange, Georgia, he returned to Birmingham, where, in 1994 he founded Birmingham Heart Clinic. The practice has grown to its present number of ten cardiologists.

    At St. Vincent’s East in Birmingham, Dr. Simpson has been Chairman of the Cardiovascular Committee, has served on the hospital Board of Directors, and been named “Outstanding Teacher” by the Family Practice resident physicians. He currently serves as Associate Clinical Professor of Medicine and Cardiology at UAB. He has been repeatedly named to “Birmingham’s Best Doctors” and “America’s Top Cardiologists.” He continues to be an investigator in numerous research and clinical trials involving carotid artery stenting, myocardial infarction, and various cardiac drugs and devices.

    Dr. Simpson is married, has three children and five grandchildren. He enjoys sports, music, humor, and spending time on his farm in St. Clair County.

  • Deepak Thekkoott, MD

    Cardiovascular Institute of the South
    Zachary, LA

    Chairman, New Cardiovascular Horizons Baton Rouge, LA

    Dr. Deepak Thekkoott, a native of India, joined Cardiovascular Institute of the South in 2008 as an interventional cardiologist. He completed his Bachelor of Medicine and Bachelor of Surgery in Kerala, India where he also received his Doctorate in Medicine. He then completed extensive training in cardiology and cardiac transplantation at the Imperial College of Medicine (Hammersmith Hospital) in London, and practiced as a staff cardiologist in the United Kingdom at the University Of Wales College Of Medicine at Cardiff, UK.

    Dr. Thekkoott undertook further cardiovascular training in Brooklyn, New York at Maimonides Medical Center, where he completed his internal medicine residency, cardiology fellowship, and interventional cardiology fellowship. Dr. Thekkoott continued his training at Lenox Hill Heart and Vascular Institute of New York in cardiovascular computed tomography (CT).

    Dr. Thekkoott is board certified in internal medicine, cardiovascular disease, interventional cardiology, nuclear cardiology, echocardiography, cardiovascular computed tomography, and endovascular medicine. He has received numerous awards including the John Goodwin Award for the best outgoing cardiologist from London University. He has also held the honor of Chief Resident elect and Chief Fellow. Additionally, much of Dr. Thekkoott’s work has been published and presented to various national societies including the American College of Cardiology, American Heart Association, American Society of Nuclear Cardiology, and the Society of Cardiac Angiography and Interventions. He has also served on multiple, national panels to discuss interventional methods and procedures.

  • Salvatore J. Tirrito, MD

    Pima Heart Associates
    Tucson, AZ

    Chairman, New Cardiovascular Horizons Tucson, AZ

    Dr. Salvatore Tirrito is a Tucson cardiologist who has dedicated his career to promoting healthy lifestyles in the community and believes in a more whole body approach to medicine. He is director of echocardiography and the co-director of vascular ultrasound at Pima Heart Associates in Tucson, Arizona and director of medical Cardiology at Tucson Medical Center.

    He specializes in primary and secondary prevention of heart disease, advanced cardiovascular imaging and vascular medicine. Dr. Tirrito is board certified in cardiology, echocardiography, nuclear cardiology and internal medicine. He holds a level III certification in cardiovascular computed tomography and has completed a fellowship in Integrative Medicine.

NCVH 2013 Annual Conference Co-Chairmen

  • Nick Cavros, MD

    Cardiovascular Institute of the South
    Lafayette, LA

    Dr. Nick Cavros is board certified in Cardiovascular Disease and Interventional Cardiology and is a fellow of the American College of Cardiology. He is presently on the medical staff of the Cardiovascular Institute of the South in Lafayette, LA and enjoys serving the local community through promoting the concept of total vascular care.

    Dr. Cavros has extensive experience in the treatment of both coronary and peripheral vascular disease and has participated in many landmark clinical trials. He lectures at national conferences as well as various practices/hospitals regarding various aspects of treatment of both coronary and peripheral arterial disease. He serves as a consultant to major medical device companies and enjoys hosting proctoring courses for some of those companies.

  • Edward B. Diethrich, MD

    Medical Director and Founder of the Arizona Heart Institute and Arizona Heart Hospital
    Phoenix, AZ

    Dr. Edward B. Diethrich, an internationally renowned cardiovascular surgeon who has practiced for more than 40 years, is regarded as one of the world’s pioneers in heart disease diagnosis and innovative cardiovascular and endovascular treatments.

    In 1971, Dr. Diethrich founded the Arizona Heart Institute and Foundation the nation’s first freestanding outpatient clinic devoted solely to the prevention, diagnosis and treatment of heart and blood vessel disease.

    Dr. Diethrich is the Medical Director and Chief of Cardiovascular Surgery at the Arizona Heart Hospital, where he performs state-of-the art cardiovascular and endovascular procedures using the latest devices, many of which he helped design and test in clinical trials.

    Dr. Diethrich’s professional accomplishments are diverse and include the development of the sternal saw used for open chest surgery and the establishment of the nation’s first outpatient cardiac catheterization laboratory. An advocate for patient education, Dr. Diethrich appears weekly on a television news program answering call-in questions and is interviewed frequently by the media.

    A graduate of the University of Michigan Medical School, Dr. Diethrich did his surgical residency training at St. Joseph’s Mercy Hospital and University of Michigan in Ann Arbor and Henry Ford Hospital in Detroit. After completing a two-year thoracic and cardiovascular surgery residency at Baylor College of Medicine under the tutelage of famed heart surgeon, Dr. Michael E. DeBakey and Dr. Denton Cooley, he remained at Baylor as assistant professor in surgery for six years.

    Dr. Diethrich is board certified in general, thoracic and cardiovascular surgery, and is a fellow of the American Colleges of Angioplasty, Cardiology, Surgery, Chest Physicians and the International College of Angioplasty. He is a member of numerous societies such as the Michael E. DeBakey International Cardiovascular Society, the Denton A. Cooley Cardiovascular Surgical Society, Society of Academic Surgeons, and is Council on Cardiovascular Disease for the American Heart Association. He is also a past president and current chairman of the Board of Directors of the International Society of Endovascular Specialists. An active member of the interventional medicine community, he belongs to more than 25 organizations, has received numerous awards and has authored several books and hundreds of scientific articles.

    He lectures and operates worldwide teaching many of the procedures developed at the Arizona Heart Institute. He provides consultation and second opinion services in addition to his operative work in all areas of cardiovascular surgery and intervention.

    Dr. Diethrich is an enthusiastic educator and an advanced scientific researcher. He is the Scientific Director of the new Arizona Heart Institute Translational Research Center. In that capacity, he guides the Institute’s investigative progress and assures that the Institute and Arizona Heart Hospital will always be on the cutting edge of cardiovascular scientific innovations, advanced patient care and human applications.

  • Eric J. Dippel, MD

    Cardiovascular Medicine, P.C.
    Davenport, IA

    Eric J. Dippel, M.D. is a private practice-based cardiovascular and peripheral vascular interventionist with Cardiovascular Medicine, P.C., Davenport, IA. and also is the President of Midwest Cardiovascular Research Foundation.

    Dr. Dippel received his undergraduate degree with departmental honors in biomedical engineering from Northwestern University. He completed his medical school and Internal Medicine residency at the University of Iowa Hospital and Clinics. He completed his general fellowship in Cardiovascular Medicine at the University of Kansas Medical Center. An advanced fellowship in coronary and peripheral vascular intervention was completed at the Ohio Heart Health Center, and the University of Cincinnati.

    Dr. Dippel is certified by the American Board of Internal Medicine in Cardiovascular Medicine, and Interventional Cardiology. He is a Fellow of the American College of Cardiology, and member of the American Heart Association Council of Clinical Cardiology, the American Medical Association, and the American College of Physicians.

    Dr. Dippel’s research interests include: adjunctive pharmacology including anti-platelet and anti-thrombin therapy, vascular inflammation, endothelial function, and new devices. He has been the principle investigator in a number of clinical trials, presented abstracts and lectured at national meetings and international meetings, and published articles in journals such as Catheterization and Cardiovascular Intervention, the Journal of Invasive Cardiology, and the Journal of the American College of Cardiology. In addition, Dr. Dippel has several patents pending for medial devices.

  • Thomas McNamara, MD

    David Geffen School of Medicine at UCLA
    Salida, CA

    Dr. McNamara accomplished his undergraduate studies at St. John's University Abbey in Collegeville, Minnesota; medical school training at the University Of Minnesota School Of Medicine in Minneapolis (AOA); Internal Medicine internship, Diagnostic Radiology residency, 1 yr Neuroradiology Fellowship at The Hospital Of The University of California in San Francisco; followed by an accelerated Fellowship In Cardiovascular Radiology at Stanford University Hospital In Palo Alto, California. He then served on the faculty at Vanderbilt University Hospitals with appointments in Neuroradiology, and Cardiovascular Radiology.

    During over a decade in private practice he made numerous scientific presentations at national & regional meetings, including the first experiences with Angioplasty of the Internal Carotid/Brachiocephalic Arteries (1982), and developed the most widely adopted method of Thrombolysis for Peripheral Occlusions. he was recruited to UCLA as Chief of Vascular Interventional radiology in 1989, and developed Thrombolytic protocols for new drugs, new infusion catheters, (patented) guidewires, Stent Delivery System, and developed the reputation for being able to treat seemingly hopeless arterial and venous problems. This expertise, and his leadership in clinical trials of new drugs and devices resulted in his becoming internationally acclaimed as an expert and author ON vascular therapies, innovations, and research.

    Dr. McNamara is Board Certified with the CAQ certification by the American Board of Radiology, a Fellow of the Society of Cardiovascular & Interventional Radiology, a Fellow of the American Heart Association, a Diplomat of the National Board of Medical Examiners and American Board of Radiology, as well as, membership in numerous other state, national imaging, International Interventional, and medical societies. His areas of clinical expertise are limb salvage, carotid/brachiocephalic stenting, congenital angioma and vascular malformation, venous occlusions, venous ulcers and varicose veins.

  • D. Christopher Metzger, MD

    Cardiovascular Associates, P.C.
    Kingsport, TN

    Dr. Metzger is a board-certified interventional cardiologist practicing with Cardiovascular Associates, P.C. in Kingsport, Tennessee. This is a 32-member group comprised of cardiologist and cardiothoracic surgeons. He received his internal medicine, cardiology, and interventional cardiology training at Wake Forest University Baptist Medical Center in Winston-Salem, North Carolina. Dr. Metzger is the Medical Director of the Cardiac and Peripheral Cath Labs at Wellmont Holston Valley Medical Center and is the Medical Director of the Clinical Research Department.

    In addition to cardiac interventions, he performs a high volume of all peripheral procedures, including carotid stenting. He is very active in clinical research, being one of the leading enrollers in multiple trials including ACT-1, Sapphire-WW, Create-PAS, Exact, CORAL, Horizons and the SUPERB Trial.

  • Ariel Soffer, MD

    Soffer Health Institute
    Aventura, Florida

    Dr. Soffer is Board Certified in Internal Medicine in 1995 and in Cardiovascular Disease in 1998 and is a Fellow in the American College of Cardiology. He was named the Chief of Medicine of Hollywood Medical Center and later became the Official Doctor and Cardiologist of the NHL’s Florida Panthers from 2004-2008. Dr. Soffer also served as the Chief of Cardiology for Jackson North Medical Center, the newest hospital in one of the world’s largest academically affiliated Hospital Systems, Jackson Health. He currently runs Soffer Health Institute in Aventura, FL.

    He is one of the first cardiologists to become proficient in the new laser treatment of Varicose Veins, an often undiagnosed vascular problem plaguing men and women of all ages. In fact, dozens of cardiologists and cardiovascular surgeons have trained in his endovenous laser ablation techniques and for which he runs a prestigious physician training program.

Connect and Share with New Cardiovascular Horizons (NCVH)